Physician profile
Michelle N Chi
NPI 1942613419
$2,745.76
in general payments reported to CMS, 2019-2025
11 companies · $322 in 2025
The $322 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,250 · 2020: $299 · 2021: $130 · 2022: $238 · 2023: $344 · 2024: $163 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $762.29 | 2019-2020 | |
| Medtronic, INC. | $513.69 | 2021-2025 | Inceptiv, Intellis Adaptivestim, Accurian |
| Mml US, INC. | $391.42 | 2022-2023 | Reactiv8 |
| Abbott Laboratories | $346.38 | 2019-2020 | |
| Spr Therapeutics, INC | $290.81 | 2023-2024 | Sprint Pns System |
| Boston Scientific Corporation | $159.40 | 2019-2020 | |
| Medtronic USA, INC. | $128.66 | 2019 | |
| Tersera Therapeutics LLC | $69.09 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $56.03 | 2019 | |
| Pacira Therapeutics, INC. | $14.13 | 2020 | |
| Amgen INC. | $13.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Chi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.